166 related articles for article (PubMed ID: 32613149)
1. Temporal dispersion in demyelination of POEMS syndrome and Castleman disease.
Lau YH; Mohd Unit H; Lee LP; Loh WK; Hiew FL
Clin Neurophysiol Pract; 2020; 5():112-117. PubMed ID: 32613149
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Guo X; Qin X; Zhang Y; Huang C; Yu G
J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
[TBL] [Abstract][Full Text] [Related]
3. [Neurophysiologic studies of POEMS syndrome and its related diseases].
Xu Y; Song H; Zhang S; Fan D
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):356-8. PubMed ID: 24746082
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic features of POEMS syndrome compared with MGUS-related neuropathy.
Kim H; Lim YM; Jin JY; Yoon DH; Suh C; Kim SY; Jo JC; Kim KK
Muscle Nerve; 2017 Dec; 56(6):E73-E77. PubMed ID: 28472865
[TBL] [Abstract][Full Text] [Related]
5. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: comparison with CIDP.
Cui RT; Huang XS; Liu JX; Chen ZH; Pu CQ
J Clin Neurophysiol; 2012 Aug; 29(4):345-8. PubMed ID: 22854769
[TBL] [Abstract][Full Text] [Related]
7. Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome.
Wang Q; Liu P; Ji LL; Wu S; Feng GD; Wang X; Dong JH
Chin Med J (Engl); 2019 Jul; 132(14):1666-1672. PubMed ID: 31268911
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological features of patients with POEMS syndrome.
Min JH; Hong YH; Lee KW
Clin Neurophysiol; 2005 Apr; 116(4):965-8. PubMed ID: 15792906
[TBL] [Abstract][Full Text] [Related]
9. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
[TBL] [Abstract][Full Text] [Related]
10. Patterns of nerve conduction abnormalities in POEMS syndrome.
Sung JY; Kuwabara S; Ogawara K; Kanai K; Hattori T
Muscle Nerve; 2002 Aug; 26(2):189-93. PubMed ID: 12210381
[TBL] [Abstract][Full Text] [Related]
11. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
[TBL] [Abstract][Full Text] [Related]
12. Motor nerve conduction study and muscle strength in newly diagnosed POEMS syndrome.
Liu M; Zou Z; Guan Y; Li J; Zhou D; Cui L
Muscle Nerve; 2015 Jan; 51(1):19-23. PubMed ID: 24752623
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of autologous peripheral blood stem cell transplantation (auto-PBSCT) on the neuropathic manifestations in POEMS syndrome].
Gronier S; Delmont E; Legros L; Launay M; Jeandel PY; Fuzibet JG; Desnuelle C
Rev Neurol (Paris); 2014 Jan; 170(1):37-45. PubMed ID: 24411685
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy.
Clouston PD; Kiers L; Zuniga G; Cros D
Electroencephalogr Clin Neurophysiol; 1994 Aug; 93(4):245-54. PubMed ID: 7521284
[TBL] [Abstract][Full Text] [Related]
15. The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease.
Mauermann ML
Hematol Oncol Clin North Am; 2018 Feb; 32(1):153-163. PubMed ID: 29157616
[TBL] [Abstract][Full Text] [Related]
16. Nerve Ultrasound Performances in Differentiating POEMS Syndrome from CIDP.
Niu J; Ding Q; Fan J; Zhang L; Liu J; Guan Y; Wu S; Cui L; Liu M
Neurotherapeutics; 2022 Mar; 19(2):455-463. PubMed ID: 35257327
[TBL] [Abstract][Full Text] [Related]
17. Temporal Dispersion and Duration of the Distal Compound Muscle Action Potential Do Not Distinguish Diabetic Sensorimotor Polyneuropathy From Chronic Inflammatory Demyelinating Polyneuropathy.
Alcantara M; Ngo M; de la Cruz J; Menon D; Barnett-Tapia C; Katzberg H; Bril V
Front Neurol; 2022; 13():872762. PubMed ID: 35557614
[TBL] [Abstract][Full Text] [Related]
18. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
19. Severe Paraproteinemic Demyelinating Neuropathy With Impaired Excitability of the Distal Segments of the Peripheral Nerves.
Khodulev VI; Kabaeva KN; Stepanova JI; Shcharbina NY
J Clin Neuromuscul Dis; 2021 Sep; 23(1):43-48. PubMed ID: 34431801
[TBL] [Abstract][Full Text] [Related]
20. Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.
Tankisi H; Otto M; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2012 Oct; 123(10):2099-105. PubMed ID: 22560637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
